Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5620(a)
Exact text from the filing
January 3, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), due to the Company not holding an annual meeting of stockholders in 2024 within one year of the Company’s 2023 fiscal year end. The Company has until February 18, 2025, which is 45 days from the date of the notice, to submit a plan to regain compliance and, if Nasdaq accepts the plan, it may grant up to 180 calendar days from the fiscal year end
Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).
Exchange
nasdaq
Notice
deficiency notice
Rules
5620(a)
Exact text from the filing
January 3, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance w
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.